Alzheimer Prevention Trials (APT) Webstudy
Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · Aug 16, 2018
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
The Alzheimer Prevention Trials (APT) Webstudy is designed to help researchers find and track people who may be at higher risk for developing Alzheimer's disease (AD) and dementia. The goal is to speed up the process of enrolling participants in future clinical trials that could lead to new treatments. If you're at least 50 years old and don't currently have dementia, you might be eligible to join this study.
Once you register, you'll participate in remote cognitive tests, which are simple assessments to check your memory and thinking skills over time. If the study identifies you as being at risk, you may also be referred for further testing to look for specific biological markers related to Alzheimer’s. Importantly, anyone can sign up for the APT Webstudy, but only those identified as at risk will proceed to the next steps. This trial is a great opportunity for individuals interested in contributing to research that could help prevent Alzheimer's disease in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • male or female at least 50 years of age
- • no evidence of dementia
- • willing to participate in remote longitudinal cognitive testing and possible referral for biomarker assessment based on risk
- Exclusion Criteria:
- • N/A. Anyone can register for the APT Webstudy, however, only individuals identified using the risk algorithm will be referred for in-person biomarker assessments.
About University Of Southern California
The University of Southern California (USC) is a prestigious research institution located in Los Angeles, California, known for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USC leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct cutting-edge research aimed at improving patient outcomes and public health. The university fosters collaboration among its diverse faculty and students, ensuring a dynamic environment for the development and implementation of clinical studies that adhere to the highest ethical and scientific standards. Through its clinical trials, USC aims to contribute to the advancement of medical science and the translation of research findings into practical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
Patients applied
Trial Officials
Paul Aisen, MD
Principal Investigator
USC ATRI
Reisa Sperling, MD
Principal Investigator
Brigham and Women's Hospital
Jeffrey Cummings, MD
Principal Investigator
The Cleveland Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials